Results 201 to 210 of about 821,521 (329)

Pseudoneurotic symptoms in the schizophrenia spectrum: An empirical study

, 2022
Andreas Rosén Rasmussen, Maja Zandersen, Julie Nordgaard, Karl Erik Sandsten, Josef Parnas   +4 more
openalex   +1 more source

The effect of gender on the long-term course and outcome of schizophrenia in rural Ethiopia: a population-based cohort [PDF]

, 2020
Rosie Mayston, Derege Kebede, Abebaw Fekadu, Girmay Medhin, Charlotte Hanlon, Atalay Alem, Teshome Shibre   +6 more
openalex   +1 more source

Author Correction: The effect of training intensity on implicit learning rates in schizophrenia

Scientific Reports, 2021
Natasza D. Orlov, Jessica Sanderson, Syed Ali Muqtadir, Anastasia K. Kalpakidou, Panayiota G. Michalopoulou, Jie Lu, Sukhi S. Shergill   +6 more
doaj   +1 more source

Unraveling the mysteries of schizophrenia: Insights into prefrontal cortex dysfunction and therapeutic implications. [PDF]

World J Psychiatry
Cheng BF, Liang Y, Wu Q.
europepmc   +1 more source

Antipsychotic medications and sleep problems in patients with schizophrenia

Erik Cederlöf, Minna Torniainen‐Holm, Heidi Taipale, Jari Tiihonen, Antti Tanskanen, Markku Lähteenvuo, Kaisla Lahdensuo, Olli Kampman, Asko Wegelius, Erkki Isometsä, Tuula Kieseppä, Aarno Palotie, Jaana Suvisaari, Tiina Paunio, Aija Kyttälä, Anders Kämpe, Annamari Tuulio‐Henriksson, Ari Ahola‐Olli, Asko Wegelius, Auli Toivola, Benjamin M. Neale, Huei-Yi Shen, Imre Västrik, Jouko Lönnqvist, Juha Veijola, Jussi Niemi-Pynttäri, Katja Häkkinen, Kimmo Suokas, Mark J. Daly, Noora Ristiluoma, Olli Pietiläinen, Risto Kajanne, Steven E. Hyman, Tarjinder Singh, Teemu Männynsalo, Tuomas Jukuri, Willehard Haaki   +36 more
openalex   +1 more source

Reduced neural connectivity in the caudate anterior head predicts hallucination severity in schizophrenia

, 2023
Leighton B. Hinkley, Shalaila S. Haas, Steven W. Cheung, Srikantan S. Nagarajan, Karuna Subramaniam   +4 more
openalex   +1 more source

Clinical Outcome Assessments in Parkinson's Disease: A Scoping Review of Current Rating Scales and Future Needs

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Clinical outcome assessments (COAs) are essential for evaluating symptom severity, treatment response, and disease progression in Parkinson's disease (PD). As clinical knowledge evolves, it is necessary to revisit the recommendation status on the COAs to ensure their continued relevance and validity. Objectives To provide an updated
Evita Papathoma, Panagiota Tsitsi, Nirosen Vijiaratnam, Camila Aquino, Stephen R. Duma, Norbert Kovacs, Kigocha Lameck Okeng'o, Aparna Wagle Shukla, Roongroj Bhidayasiri, Tiago A. Mestre, Alvaro Sanchez Ferro, Alberto J. Espay, Michelle H.S. Tosin, Matej Skorvanek, Ioanna Markaki   +14 more
wiley   +1 more source

The fundamental disturbance (Grundstörung) of schizophrenia (Part 1): Acquiring a potent endophenotype, exploratory eye movement. [PDF]

PCN Rep
Kojima T, Matsushima E.
europepmc   +1 more source

Basal Forebrain Volume and Concurrent Hallucinations and Mild Cognitive Impairment in Parkinson's Disease

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Visual hallucinations (VH) and mild cognitive impairment (MCI) often co‐occur in Parkinson's Disease (PD). Each symptom in isolation is associated with cholinergic basal forebrain (BF) atrophy. However, it is unclear whether BF integrity relates to one symptom preferentially or to their co‐occurrence, and whether this relationship ...
Sabrina M. Adamo, Vaishali Mutreja, Marta Statucka, Batu Kaya, Taylor W. Schmitz, Anthony C. Ruocco, Melanie Cohn   +6 more
wiley   +1 more source

The Ketogenic Diet: An Anti-Inflammatory Treatment for Schizophrenia? [PDF]

J Inflamm Res
Hung AA, Krycer JR, Sarnyai Z, Palmer CM, Navarro S.   +4 more
europepmc   +1 more source